Drawing for ETROFLYT

USPTO serial 79020861

ETROFLYT

Reviewed by CopyMark Law Group

Reg. 3159209Status 404
Filing date
Status date
Registration date
Oct 17, 2006
Examiner
ORNDORFF, LINDA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ETROFLYT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III (Christine S. Beaman, M. Christopher Bolen, Kathryn M. Eyster, Jack B. Hicks, Sarah Anne Keefe, Fang Liu, Jeffrey R. McFadden, C. Robert Rhodes, Randel S. Springer, Maury M. Tepper, III, Mitchell A. Tuchman)

Maury M. Tepper, III (Christine S. Beaman, M. Chri Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and/or treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacterial-based disease, antivirals, antibiotics, and antifungalsSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 18, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 18, 2026DETHDEATH OF INTERNATIONAL REGISTRATION
Mar 24, 2017GPNXNOTIFICATION PROCESSED BY IB
Dec 30, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 30, 2015DETHDEATH OF INTERNATIONAL REGISTRATION
Dec 11, 2014GPNXNOTIFICATION PROCESSED BY IB
Nov 14, 2014OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 19, 2013DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 18, 2013DETHDEATH OF INTERNATIONAL REGISTRATION
Apr 12, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 23, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 18, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 9, 2006ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 9, 2006REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 17, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 1, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 12, 2006NPUBNOTICE OF PUBLICATION
Jun 14, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 9, 2006ALIEASSIGNED TO LIE
May 23, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 23, 2006DOCKASSIGNED TO EXAMINER
Mar 24, 2006NWAPNEW APPLICATION ENTERED
Mar 23, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance